Clinical Trial Update: Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing risperidone alone versus risperidone plus low-dose haloperidol for schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Kaohsiung Kai-Suan Psychiatric Hospital | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED